This protocol combines mass photometry with a novel microfluidics system to investigate low-affinity protein-protein interactions. This approach is based on the rapid dilution of highly concentrated complexes in solution, which enables low-affinity measurements and broadens the applicability of mass photometry.
Mass photometry is a versatile mass measurement technology that enables the study of biomolecular interactions and complex formation in solution without labels. Mass photometry is generally suited to analyzing samples in the 100 pM-100 nM concentration range. However, in many biological systems, it is necessary to measure more concentrated samples to study low-affinity or transient interactions. Here, we demonstrate a method that effectively expands the range of sample concentrations that can be analyzed by mass photometry from nanomolar to tens of micromolar.
In this protocol, mass photometry is combined with a novel microfluidics system to investigate the formation of protein complexes in solution in the micromolar concentration range. With the microfluidics system, users can maintain a sample at a desired higher concentration followed by dilution to the nanomolar range - several milliseconds prior to the mass photometry measurement. Due to the speed of the dilution, data is obtained before the equilibrium of the sample has shifted (i.e., dissociation of the complex).
The technique is applied to measure interactions between an immunoglobulin G (IgG) antibody and the neonatal Fc receptor, showing the formation of high-order complexes that were not quantifiable with static mass photometry measurements.
In conclusion, the combination of mass photometry and microfluidics makes it possible to characterize samples in the micromolar concentration range and is proficient in measuring biomolecular interactions with weaker affinities. These capabilities can be applied in a range of contexts - including the development and design of biotherapeutics - enabling thorough characterization of diverse protein-protein interactions.
Protein-protein interactions underline most cellular functions, from immune regulation to DNA replication and translation. As a result, there is a fundamental need throughout the life sciences to investigate a vast range of interactions across diverse heterogenous complexes that are commonly formed. However, their detection, characterization, and quantification are often challenging, particularly for low-affinity interactions1.
Immunoprecipitation assays are often used to detect high-affinity interactions, but for low-affinity and transient interactions, detection is largely unfeasible2. Fluorescence techniques can also be used but require the potentially disruptive addition of fluorescent labels2. Cryo-EM can provide a structural snapshot and an ensemble readout of the protein complexes formed with high spatial resolution but also typically requires working at concentrations that are too low for imaging low-affinity interactions. Cryo-EM also brings challenges related to cost, accessibility, sample preparation, and analysis time3.
Additionally, surface plasmon resonance (SPR) has become a popular way to quantify protein-protein interactions, although it requires protein immobilization, which can affect the binding equilibrium and result in variable on-rates, thus reducing measurement accuracy4,5. It also involves several assay steps prior to data collection and analysis6.
Mass photometry is a single-molecule technique that has been used to analyze protein-protein interactions5,6,7. It works by measuring the mass of single molecules or complexes based on the light they scatter when they land on the surface of a glass coverslip8. Mass photometry measurements have been used to quantify binding affinities from the relative abundance of binding partners and the complexes they form5. Nevertheless, like other single-molecule techniques, the concentration of the sample to be measured should typically be less than 100 nM. If the concentration is higher, the molecules landing on the glass surface will overlap spatially, resulting in poor data quality7. Consequently, weaker interactions (KD ~micromolars), which dissociate at these lower concentrations, cannot be measured reliably since it is not possible to observe the necessary mixture of unbound and bound species5.
Here, we describe an approach that overcomes this limitation based on a new coupled microfluidics mass photometry device. Specifically, a microfluidics system is used in combination with the mass photometer to effectively expand the range of interactions that can be quantified by mass photometry. Microfluidics has been shown to offer a range of possibilities for investigating protein-protein interactions, including rapid dilution to detect weak interactions1,9. The system described herein operates by rapidly diluting the sample up to 10,000-fold on a microfluidic chip and immediately flowing it across the observation area of the chip, enabling the mass photometry measurement to start within 50 ms from when the molecules began the dilution process10. The dilution occurs when the sample and buffer are combined in a reverse Tesla valve mixer on the chip, with the relative flow rates of the two solutions determining the amount of dilution that occurs (see Protocol step 8). The flow rate is controllable with the microfluidic control software. Altering the flow rate can change the relative population of the species as it can impact the number of landing events on the surface of the glass, which is what is measured by the mass photometer.
The speed of the process is fast enough for the measurement to be completed before the integrity of the interaction has been disrupted (for further details, see also the Discussion). This can be understood through a brief look at the theory of first-order reactions, where . The forward (association) rate constant is kf, the backward (dissociation) rate constant is kb, and the equilibrium dissociation constant (KD) is defined as
KD = kb / kf
For protein binding, kf is generally limited by the reactants' diffusion11 and so is restricted to the range of 106-107 M-1·s-1. Because the range of is limited, a low-affinity (KD ~micromolars) reaction will have kb ≈ 1 s-1. That is, kb = kf · KD = (106 M-1·s-1) (10-6 M) = 1 s-1, with the complex's half-life around 0.7 s11,12.
Our example system is the binding of the IgG monoclonal antibody trastuzumab to the soluble domain of the IgG neonatal Fc receptor (FcRn), which are known interacting partners13. Previously published data obtained using conventional mass photometry alone (i.e., with manual dilution of samples) showed that the proteins form multiple species. FcRn monomers, FcRn dimers, and unbound IgG were clearly visible, while IgG-FcRn complexes (at 1:1 and 1:2 ratios) were also detected (at pH 5.0) but only with very low abundance5. This observation prompts the question of whether IgG-FcRn complex formation could be more clearly detected if measured at a higher concentration. Indeed, combining mass photometry with a coupled rapid dilution approach described here provided more robust evidence of complex formation by an increase in their measured particles.
The mass photometry and microfluidics protocol described here makes it possible to characterize the formation of complexes with a KD up to the micromolar range. An empirical determination of the KD will require further improvements on the flow sensor accuracy, pump stability, chip-to-chip variations, and measurement location inside the observation window, as all these factors would influence the time from when the sample is diluted to being measured.
The same approach could be applied to investigate binding among any soluble proteins, provided they have distinct molecular weights (separated by at least 25 kDa) that fall into the range suitable for analysis with a mass photometer (30 kDa to 6 MDa). The insights obtained could be helpful for studies in a range of contexts - from gaining a mechanistic understanding of cellular functions to the design of new biotherapeutic drugs.
1. Preparing the instruments and launching the software
2. Preparing protein samples, buffer, and cleaning solutions
3. Experimental set-up
4. Priming the sample and buffer lines with buffer
5. Placing the microfluidics chip onto the mass photometer and finding the focus
6. Mass photometry calibration
7. Cleaning the sample line and stopping the flow
8. Measuring the mass photometry sample
9. Data analysis
Mass photometry was used to measure the interaction between the IgG monoclonal antibody trastuzumab and the soluble domain of the IgG neonatal Fc receptor (FcRn). A 1:10 mixture of the two proteins (at 2 µM for IgG and 20 µM for FcRn) was diluted manually to 10 nM and 20 nM in PBS, respectively.
The dilution step is necessary because mass photometry, a single-molecule mass measurement technique, can only analyze samples in the 100 pM-100 nM range. Attempting to measure samples with concentrations outside this range can jeopardize the accuracy of the results (Figure 4).This experiment is not included in this Protocol, as it has been described previously5,6.
In the mass histograms produced in a mass photometry experiment, the strength of the scattering signal (or 'contrast') for each landing event is plotted on the x-axis, and it is converted to molecular mass via the mass-contrast calibration step. Meanwhile, the y-axis indicates the number of molecules counted with a given mass (or contrast). Therefore, a peak indicates the presence of a population of molecules within the range of molecular weights shown on the x-axis. The number of events (counts) that make up the peak reflects the size of that population.
The mass photometry measurement with manual dilution resulted in a mass histogram where the two largest peaks, based on the proteins' expected molecular weights, corresponded to unbound FcRn monomers (~50 kDa) and IgG antibody monomers (~150 kDa) (Figure 7). Similar to the previously published mass photometry data5, the unbound species were prominent, while peaks in the mass ranges that would correspond to complexes were much less apparent.
The experiment was repeated using a rapid-dilution microfluidics system to dilute the mixture to the necessary concentration immediately prior to the mass photometry measurement. This approach enabled the detection of additional low-affinity complexes, which may have dissociated during the manual dilution step. To achieve the same 2000x dilution factor used during the manual dilution experiment, the 1:10 sample mixture (at 2 µM concentration for IgG and 20 µM for FcRn) was flowed onto the microfluidic chip at a rate of 0.5 µL/min, along with PBS buffer (pH 5.0) at a flow rate of 1 mL/min. To ensure that the proteins were not degraded at the time of the measurement, IgG (2 µM) and FcRn (20 µM) were measured under flow with the microfluidics system following 120 min of incubation of the samples. Individual control measurements showed no protein degradation (Supplementary Figure 1)
For the sample that underwent rapid dilution, the peaks corresponding to FcRn monomers (53 kDa), FcRn dimers (97 kDa), and IgG monomers (148 kDa) could again be observed. Also, two additional peaks were clearly observed at 196 kDa and 251 kDa, corresponding to IgG-FcRn complexes with 1:1 and 1:2 stoichiometries (Figure 7). The expected masses for these two complexes were 200 kDa and 250 kDa, respectively. The variability in the mass measurement is within the measurement error for the mass photometer used in this study is ±5%14 (2% for the 1:1 complex and 0.4% for the 1:2 complex).
The presence of these complexes in only the rapidly diluted sample is consistent with the idea that they tend to dissociate at lower concentrations, at a rate that is fast relative to a manual dilution process but slow relative to the process of rapid dilution achieved with the microfluidics system15.
Figure 1: Combining microfluidics with mass photometry. (A,B) The microfluidics box used in this protocol, as seen from the (A) front and (B) top. The cleaning solutions are placed in positions 1-3, and the samples and calibrants in positions 4-6. All solutions are connected to the m-switch, which is connected to the "Small" flow unit sensor. (C) Overview of the entire system. The computer (top left) is connected to microfluidics box (shown adjacent to the buffer and sample tubes) and the mass photometer (bottom right), where the microfluidics chip is located. The small flow rate monitor (FRMS) monitors flow through the sample line, while the large flow rate monitor (FRML) monitors buffer flow. The sample and buffer line tubing connect to a channel on the microfluidics chip, placed inside the mass photometer. (D) Each chip has three channels. The FRMS is connected to the sample inlet and FRML to the buffer inlet. The mixer area is where rapid sample dilution takes place, while the observation area is where the mass photometry measurements are done. The outlet is monitored by an additional flow sensor to ensure there are no leaks in the chip. Please click here to view a larger version of this figure.
Figure 2: The microfluidics control software. With this software, set and monitor the flow rates, the pressure lines of the microfluidics system, and the position of the multi-switch (m-switch). Please click here to view a larger version of this figure.
Figure 3: Identifying the presence of bubbles in the oil. The examples from the data acquisition software show a clear, unbroken focus ring (left) and a 'broken' ring, indicating the presence of air bubbles in the immersion oil (right). Please click here to view a larger version of this figure.
Figure 4: Representative examples of sample concentrations where the number of molecule landing events is too few, ideal, or too many. Molecules landing on the surface of the observation area in the microfluidics chip will appear as dark spots in the ratiometric view of the mass photometry image. Optimally, the desired concentration should enable an ideal density of landing events to take place during data acquisition (middle). If the landing event density is too low (top, 'Too few'), accurate statistical analysis of the mass photometry data cannot be completed. If it is too high (bottom, 'Too many'), the landing molecules will overlap spatially, which will result in poor data quality. These images were captured with the data acquisition software using a mass photometer. Please click here to view a larger version of this figure.
Figure 5: A screen capture of the data analysis software for mass photometry. Here, the .mp files exported from the data acquisition software can be loaded to analyze the data. Figures can be generated from the processed data. Please click here to view a larger version of this figure.
Figure 6: A screen capture of the mass-contrast calibration for this experiment. The calibrant used was β-Amylase, which is known to form three species: monomer (56 kDa), dimer (112 kDa), and tetramer (224 kDa). Please click here to view a larger version of this figure.
Figure 7: Mass histograms reveal complex formation only after rapid sample dilution. Mass histograms and corresponding best-fit Gaussian distributions are shown for measurements of samples containing IgG and FcRn following manual dilution (orange) or rapid dilution via the microfluidicsHC system (blue). The mass labels indicate that the mean values from the Gaussian curves fit the mass histograms measured after rapid dilution. After manual dilution, peaks corresponding to FcRn monomers (52 kDa, as measured with manual dilution) and IgG monomers (152 kDa) were observed. After rapid dilution, in addition to the FcRn and IgG monomers, peaks corresponding to FcRn dimers and IgG-FcRn complexes with 1:1 and 1:2 stoichiometry were also clearly observed. Please click here to view a larger version of this figure.
Supplementary Data Figure 1: Mass photometry measurements of control samples after rapid dilution show no protein degradation. (A) Mass histogram and best-fit Gaussian distribution for the FcRn-only sample. The initial sample concentration prior to rapid dilution was 20 µM, and the flow rate was set to 0.5 µL/min. Mass peaks corresponding to FcRn monomers (53 kDa) and FcRn dimers (97 kDa) could be observed. (B) Mass histogram and best-fit Gaussian distribution for the IgG (Herceptin) only sample. The initial sample concentration prior to rapid dilution was 2 µM, and the flow rate was set to 1 µL/min. A single mass peak corresponding to IgG monomer (155 kDa) could be observed. Please click here to download this File.
The protocol outlined here provides a method for detecting and quantifying low-affinity protein-protein interactions. It uses a mass photometer coupled to a rapid-dilution microfluidics system. Mass photometry is a label-free, bioanalytical tool that can reliably measure molecular mass in solution for biomolecules16, for those within the range of 30 kDa to 6 MDa. As mass photometry is a single-molecule technique that analyzes samples one by one, it is generally limited to samples in the 100 pM-100 nM concentration range. Above this range, the molecules landing on the glass surface will overlap spatially, resulting in poor data quality; below this range, too little data is obtained to do robust analysis7. An important consequence is that it can limit the investigation of protein interactions to those that form a mixture of bound and unbound species within that range.
Here, we detailed a step-by-step protocol for using a rapid-dilution microfluidics system to effectively expand the range of sample concentrations that are amenable to mass photometry. By diluting the sample on the microfluidic chip and then flowing it across the detector observation window within 50 ms, the system captures the complexes present in the undiluted sample before the interaction equilibrium shifts. The sample is continuously delivered to the detector during individual measurements. Under these conditions, 95% of the complex will remain intact when the sample is measured, even for low-affinity interactions - with a KD on the order of micromolars and dissociation rates as fast as 1 s-1.
This can be calculated as follows: For a reaction with a forward rate kf and backward rate kb,
At equilibrium, the concentrations of all three species (A, B, and the complex AB) stay constant, so and . Under the conservative assumption that the perturbation (dilution, in this case) may cause the complex to dissociate, but the forward (association) reaction does not proceed, the term kf [A] [B] can be treated as negligible, and the following simplification can be made:
Integrating gives the following expression for the concentration of complex at time after the perturbation of equilibrium:
The fraction of the complex that remains bound at time t after the perturbation of equilibrium is thus:
At = 50 ms, for a reaction with kb ≈ 1 s-1, the fraction bound is 0.95, or 95%11,12.
Mass photometry was used here and previously5 to investigate the binding of the IgG monoclonal antibody trastuzumab to the soluble domain of the FcRn. The two binding partners have been reported to bind with nanomolar affinity at acidic pH17. Mass photometry was used to qualitatively assess the abundance of the complexes formed while the binding partners were at pH 5.0, and the samples were rapidly diluted through an additional microfluidic system. The procedure was optimized for the particular protein-protein interaction based on previously reported results5. The same procedure can be used to study other interactions, provided the users have prior knowledge or optimize the experimental conditions for the system in question, such as which buffers to use, the initial protein concentration, the expected stoichiometry, and the amount of incubation needed to allow the interaction to reach an equilibrium.
When the IgG-FcRn mixture was diluted manually, it was difficult to detect the presence of IgG-FcRn complexes, even though these proteins are known to interact5. This paper shows that the rapid dilution approach results in a notably increased amount of these complexes. For the same sample, when rapid dilution was used, 1:1 FcRn-IgG complexes and 2:1 FcRn-IgG complexes were both clearly observed. These differences in complex formation demonstrate the importance of studying biomolecular interaction systems across a broad range of concentrations.
Additionally, these results also demonstrate that it is straightforward to use microfluidics with single-molecule analysis to capture weak interactions - filling a significant gap in the method. The combination of rapid-dilution microfluidics with mass photometry offers attractive advantages due to the advantages of mass photometry as an analytical technique. That is, mass photometry does not require labels, involves minimal sample preparation, and the measurements are done in solution. For this protocol, another key advantage of mass photometry is its ability to distinguish and quantify all the species formed (provided they have a distinct mass of >30 kDa). This is in contrast to SPR, for example, which can measure rates of binding and unbinding but cannot readily provide stoichiometry information8.
For this protocol, as well as mass photometry experiments more generally, several considerations are helpful. First, the final protein concentration should be within the limit of what mass photometry can measure (100 pM-100 nM). The starting incubation concentration should also be within the range of the microfluidic system (up to 90 µM) and theorized to be above the actual KD of the interaction10. The recommended starting point is a 1:1 concentration mix ratio between the interacting species at µM concentration. The ratio could then be varied to 1:2, 1:5, or, as in the case of this interaction, 1:10. If there is no previous information about the protein interactions, the user would have to optimize the experiment, starting with a high concentration (recommended 20 µM) for each partner to determine if the affinity of the components is within the concentration range sustained by the method presented (i.e., complexes are formed). Optimization might also involve choosing other buffer conditions to promote the interactions or titration of one of the interaction components to determine the right mixing ratio. Once these are determined, it is possible to optimize concentrations and flows to allow optimal conditions for the study and method, e.g., decreasing the concentrations to allow better peak resolution.
Secondly, to successfully replicate this experiment, impurities should be minimized. Common sources of impurities that are known to adversely affect mass photometry measurements include other proteins or cellular debris that remains after purification, unfiltered buffers, micelle-forming detergents (if present at too high a concentration), and buffers containing high concentrations of salt, glycerol, or other components. As discussed in the Protocol above, bubbles in the microfluidics system should be removed. Bubbles can form in the tubing system or if samples have high surface tension and are prone to foam formation. Bubbles can also form in the immersion oil, which can be detected from the focus ring (Figure 3). If bubbles cannot be removed using the steps described in the protocol, another solution is to degas the sample using a desiccator and a vacuum pump, leaving the sample under reduced pressure for a few minutes. Vortexing or shaking highly concentrated protein solutions is not recommended as these actions may promote bubble formation.
While the measurement of one specific protein-protein interaction is demonstrated here, the same protocol can be applied to other protein-protein interaction systems without significant modification. A further future direction of this protocol would be to use the measurements to calculate KD values for the complexes identified, as has been described elsewhere in the context of mass photometry5,7. While the prior studies used data from experiments involving manual dilution and stronger interactions, the analysis principle could be readily applied in this context - provided further improvements in the microfluidic device are implemented (such as increased flow sensor accuracy and pump stability).
Beyond protein-protein interactions, there are likely to be wider applications for the combined mass photometry and rapid-dilution microfluidics approach. Mass photometry can be used to assess sample purity, aggregation, and homogeneity18,19; study protein oligomerization20, macromolecular assembly21 or polymerization22; and in other areas. Mass photometry analysis also extends beyond proteins; it has been used to investigate interactions between nucleic acids and proteins23, viral particles24, and nanoparticles25. This protocol thus describes an important application of a combined mass photometry microfluidics system - it enables the direct measurement of weak protein-protein interactions at the level of individual molecules and complexes. The value of the present application is high, as it opens the possibility of straightforwardly characterizing interactions that have generally been difficult to study - with relevance across critical therapeutic areas. This combined approach could also serve as the basis for a broader range of investigations for samples with concentrations up to the tens of micromolar.
W.S. is supported by a UKRI Future Leaders Fellowship [MR/V02213X/1]. The manuscript text and graphics were prepared with support from members of Refeyn's scientific communications team (Panagiota Paganopoulou, Neus Torres Tamarit, and Catherine Lichten). We also acknowledge valuable feedback from Camille Hetez, Sofia Ferreira, and Matthias Langhorst.
Name | Company | Catalog Number | Comments |
2-Propanol (Isopropanol) | VWR International LLC | 20880.320 | |
Data acquisition software | Refeyn | AcquireMP (v2022 R1) | |
Data analysis software | Refeyn | DiscoverMP (v2022 R1) | |
FCRN, His-Tag | Sigma | SRP0624 | |
Herceptin (IgG)Â | Cambridge Bioscience | HY-P9907-1mg | |
Mass photometer | Refeyn | TwoMP | |
Microfluidics box | Refeyn | MassFluidix HC system | |
Microfluidics chip | Refeyn | MassFluidix HC chip | |
Microfluidics control software | Fluigent | OxyGEN | |
Phosphate Buffered Saline (PBS), 1x Ultra Pure | VWR International LLC | K812 | |
Sodium Hydroxide (NaOH)Â | Sigma | S2770 | |
β-Amylase, from sweet potato | Sigma | A8781 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved